Corporate Profile

Aeterna Zentaris Inc. (TSX: AEZ, NASDAQ: AEZS) is a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health.

Contacts

USA
Aeterna Zentaris, Inc.
315 Sigma Drive, Suite 302D
Summerville, SC 29483
Phone: (843) 900-3223
website: www.aezsinc.com

Germany
Aeterna Zentaris GmbH
Weismüllerstrasse 50
60314 Frankfurt
Germany
Phone: +49 69 42602 3228







Aeterna Zentaris Announces Special Meeting of Shareholders and Mailing of Management Information Circular more...>

Aeterna Zentaris: Data and Safety Monitoring Board Recommends Continuation of ZoptEC Phase 3 Trial in Advanced Endometrial Cancer more...>

Aeterna Zentaris Announces Restructuring of Finance & Accounting Operations and Closure of Quebec City Office more...>

Aeterna Zentaris’ Zoptarelin Doxorubicin Meets Phase 2 Primary Endpoint in Men with Heavily Pretreated Castration and Taxane Resistant Prostate Cancer more...>

Aeterna Zentaris Announces TSX Approval of Series B Warrant Amendment more...>


 
Download PDF (125K)
Download and install Acrobat Reader